Abstract-Greater phosphorus intake has been associated with lower levels of blood pressure in cross-sectional studies.
S
ubstantial evidence demonstrates that dietary factors affect the risk of hypertension. 1 A diet rich in potassium, fruits, vegetables, and low-fat dairy products that is low in sodium and alcohol intake has been consistently associated with reduced levels of blood pressure (BP). 2, 3 The effect of other nutrients, such as calcium, magnesium, fiber, protein, or phosphorus is less clear. 1 A recent analysis from the International Study of Macroand Micro-Nutrients and Blood Pressure, an international cross-sectional study including 4680 individuals, showed that a higher phosphorus intake, independent of other nutrients, was associated with lower BP levels. 4 Similarly, in the US National Health and Nutrition Examination Survey, phosphorus intake presented a weak inverse association with systolic and diastolic BPs. 5 No prospective studies, however, have examined whether phosphorus intake might be associated with a reduced risk of hypertension.
Determining the relationship between dietary phosphorus and the risk of incident hypertension is particularly relevant, because phosphorus in the diet could affect levels of serum phosphorus, as shown in some studies 6 -8 (although not in others). 9 -11 Elevated serum phosphorus levels, in turn, could increase the risk of cardiovascular events. [12] [13] [14] In addition, the intake of phosphorus in the US population has increased considerably in the last decades, particularly because of the important amount of phosphorus food additives in processed foods. 15 Therefore, assessing the overall cardiovascular effect of dietary phosphorus, whether beneficial or deleterious, is a crucial public health need.
We examined the association of phosphorus intake with BP levels and risk of hypertension in 2 population-based studies in the United States: the Atherosclerosis Risk in Communities (ARIC) Study and the Multi-Ethnic Study of Atherosclerosis (MESA). In addition, we assessed whether phosphorous from different dietary sources was equally related to hypertension.
Methods

Study Population
The ARIC Study is a population-based cohort study aimed to identify risk factors for cardiovascular diseases in 4 US communities. 16 Between 1987 and 1989, 15 792 men and women aged 45 to 64 years were recruited from Washington County, Md; Forsyth County, NC; Jackson, Miss; and suburbs of Minneapolis, Minn. Participants underwent a baseline clinical examination. Follow-up examinations of the cohort occurred 3 times, at intervals of Ϸ3 years. The sample included 27% blacks and 73% whites.
From July 2000 to September 2002, MESA recruited 6814 men and women, aged 45 to 84 years and free of cardiovascular disease, from 6 different populations in the United States: Baltimore, Md; Chicago, Ill; St Paul, Minn; Forsyth County, NC; New York, NY; and Los Angeles, Calif. 17 MESA conducted 3 follow-up examinations between 2002 and 2007. The race/ethnicity distribution was 41% white, 26% black, 21% Hispanic, and 12% Chinese-American.
Study participants who at baseline had diabetes mellitus or cardiovascular disease or were taking antihypertensive medication were excluded from all of the analyses. We also excluded individuals with missing values in any of the covariates or who provided insufficient or implausible dietary information (missing diet data or extreme energy intake, as described elsewhere). 18, 19 In the longitudinal analysis, we additionally excluded those who did not attend any follow-up visit or had systolic BP Ն140 mm Hg or diastolic BP Ն90 mm Hg at the baseline examination. Finally, in the ARIC Study, we excluded a small number of individuals who were not white in the Minnesota and Washington County sites or not white or black in the Forsyth County site; these exclusions were done to allow multivariate adjustment for race and study site. Response rates among survivors for the successive examinations were 93%, 86%, and 80% in the ARIC Study and 91%, 87%, and 85% in MESA.
Institutional Review Boards from all of the participating institutions approved the study. Study participants provided written informed consent.
Diet Assessment
In the ARIC Study, diet was assessed at baseline using a 66-item food frequency questionnaire (FFQ) on the basis of the 61-item FFQ developed by Willett et al. 20 Participants reported usual frequency of food consumption in 9 categories, from never or less than once a month to Ն6 times per day. Average daily intake of nutrients was calculated by multiplying the frequency of consumption of each food item by its nutrient content and adding up the nutrient intake for all of the items.
Dietary data in MESA was assessed at baseline using a 120-item FFQ, developed according to the validated Block format. 21 The MESA FFQ was adapted from the Insulin Resistance Atherosclerosis Study FFQ, modified to include unique Chinese foods and culinary practices. Information from the food-specific portion of the questionnaire was converted to approximate daily intake amounts of the micronutrients in the food using the Nutrition Data Systems for Research database (Nutrition Coordinating Center University of Minnesota). 22 Nutrient intake was adjusted for total energy intake using the residual method and categorized in sex-specific quintiles. 23 
BP Measurement
At the ARIC Study baseline and follow-up visits, BP was measured by certified technicians with a random-0 sphygmomanometer. The second and third of 3 measurements were averaged to estimate systolic and diastolic BPs. In MESA, BP was also measured at baseline and at each follow-up examination. Three seated BP measurements were taken 5 minutes apart by using an automated device (Dinamap Pro 100). The mean of the last 2 measurements was considered for analysis. The use of antihypertensive medication was assessed by questionnaire at all of the visits in both the ARIC Study and MESA. A study participant was labeled as hypertensive (prevalent or incident) if she or he had systolic BP Ն140 mm Hg, diastolic BP Ն90 mm Hg, or was currently using antihypertensive medication.
Assessment of Other Covariates
Measurement of other covariates is detailed in an online Data Supplement. Please see http://hyper.ahajournals.org for details.
Statistical Analysis
Analyses were conducted separately in each cohort. Heterogeneity between cohorts was assessed with the Cochran Q statistic. 24 If no evidence of heterogeneity was apparent, cohort-specific results were pooled, weighted by the inverse of their variance.
To study the cross-sectional association between baseline phosphorus intake and BP levels, we fitted separate multiple linear regression models for systolic and diastolic BPs. An initial model included quintiles of phosphorus intake, as a categorical variable, with age, sex, and race as adjustment variables. In a subsequent model, we added the following potential confounders: study site, body mass index (considered as a continuous variable), waist circumference (continuous), education (ordinal), income (ordinal), physical activity (continuous), estimated glomerular filtration rate (eGFR; continuous), cigarette smoking (current, former, or never), alcohol intake (continuous), and energy intake (continuous). Finally, a third model additionally adjusted for quintiles of other nutrients and foods: calcium, potassium, magnesium, sodium, vitamin D (only in the ARIC Study), daily servings of fruits and vegetables, and daily serving of whole grains.
In the longitudinal analysis, we estimated hazard ratios (HRs) of incident hypertension and their 95% CIs by quintiles of phosphorus intake using Cox proportional hazards regression, with the lowest quintile as the reference category. The main independent variable was time from baseline examination to the examination date in which hypertension was first diagnosed. Study participants were censored if they did not have hypertension by the time of their last study visit. As with the cross-sectional analysis, we ran different models including increasing number of potential confounders. Trends across quintiles of phosphorus intake were estimated assigning the quintile-specific median intake of phosphorus to all of the individuals in that quintile and including the resulting value as a continuous variable in regression models.
If a nutrient is related to an outcome, the association should be seen independently from the food from which it is derived. Because dairy products are the main source of dietary phosphorus, and given the known inverse association between dairy product intake and the risk of hypertension, we conducted separate analyses using dietary phosphorus from dairy products and dietary phosphorus from other sources as main exposure variables. Phosphorus intake from different sources was calculated with a cohort-specific multivariable regression model, with daily phosphorus intake as the dependent variable and daily servings of each food item in the FFQ as independent variables. The coefficients obtained from this model were multiplied by the average number of servings per day for each food item, providing the average daily phosphorus intake from the corresponding food.
In the online Data Supplement, we have included additional details on sensitivity and stratified analyses (please see http:// hyper.ahajournals.org). All of the statistical analyses were conducted using SAS version 9.2 (SAS Inc).
Results
From the initial 15 792 ARIC and 6814 MESA participants, 9785 from the ARIC Study and 3659 from MESA met inclusion criteria for the cross-sectional analysis. Of these, 8208 ARIC and 2901 MESA participants were also included in the longitudinal analysis. Figure 1 presents a flow diagram of participants in the ARIC Study and MESA and the different reasons for exclusion. In both studies, the main reason for exclusion was the use of antihypertensive medications or high BP levels at baseline. Tables 1 and 2 report selected characteristics of ARIC and MESA participants by sex-specific quintiles of phosphorus intake. Average phosphorus intake was similar in both cohorts (1084 mg/d in the ARIC Study; 1103 mg/d in MESA). Individuals with higher phosphorus intake were older, more likely to be educated, and had an overall healthier lifestyle profile than those with low phosphorus intake. Thus, they were more likely to be nonsmokers and physically active, had lower alcohol intake, and had higher intake of calcium, potassium, magnesium, sodium, fruits and vegetables, and whole grains. Whites had higher phosphorus intake and, in MESA, blacks had lower phosphorus intake than Chinese-Americans and Hispanics. Correlations between phosphorus and other dietary minerals were relatively strong: 0.80 and 0.92 with calcium, 0.66 and 0.68 with potassium, and 0.66 and 0.69 with magnesium, in the ARIC Study and MESA, respectively.
In the baseline cross-sectional analysis, higher phosphorus intake was associated with lower levels of systolic and diastolic BPs in both cohorts, even after adjustment for potential confounders ( During an average follow-up of 6.2 years (7.1 in the ARIC Study and 3.8 in MESA), 3345 incident cases of hypertension (2400 in the ARIC Study and 945 in MESA) were identified. Individuals in the top quintile of phosphorus intake had an Ϸ10% lower risk of hypertension than those in the lowest, after adjustment for potential confounders ( In analyses stratified by sex, greater phosphorus intake was similarly associated with lower risk of hypertension in men and women. The HR (95% CI) of hypertension comparing extreme quintiles of phosphorus intake was 0.86 (0.72 to 1.03) in men and 0.93 (0.80 to 1.09) in women (Tables S1 and  S2 , available in the online Data Supplement at http://hyper. ahajournals.org). Results stratified by race/ethnicity did not provide strong evidence of interaction, although the limited sample size among nonwhites precluded drawing any meaningful conclusion (Tables S3 and S4 ). Finally, no evidence of interaction by renal function was apparent (data not shown).
The main source of dietary phosphorus in both cohorts was dairy products (31% in the ARIC Study and 29% in MESA), followed by fish (7%), red meat (7%), poultry (5%), and whole-grain bread (5%) in the ARIC Study and by white bread (6%), red meat (5%), whole grain bread (5%), and legumes (5%) in MESA. We estimated separately the association of phosphorus intake from dairy and nondairy sources with cross-sectional BP levels and the risk of incident hypertension. Results are shown in Figures 2 and 3 . Overall, only higher phosphorus intake from dairy products, but not from other dietary sources, was consistently associated with lower levels of systolic BP and lower risk of hypertension.
We conducted an additional analysis correcting diet measurement error using regression calibration. 25 A 500-mg/d higher phosphorus intake was associated with 1.1-mm Hg lower systolic BP (95% CI: 0.5 to 1.8 mm Hg) in the uncorrected analysis and 2.1 mm Hg (95% CI: 1.1 to 3.0 mm Hg) in the corrected analysis. HR (95% CI) of hypertension associated with the same difference in phosphorus intake was 0.93 (0.87 to 1.00) in the uncorrected analysis and 0.88 (0.79 to 0.99) in the corrected (detailed results are presented in Tables S5 and S6) .
Discussion
In this analysis of 2 large population-based cohorts, we have found that phosphorus intake was inversely associated with systolic BP levels, even after adjustment for confounders and highly correlated nutrients. In addition, we observed a lower risk of hypertension among individuals with a higher phos- phorus intake, but this association was considerably attenuated after adjusting for other dietary factors. More importantly, we found that these associations were only present for dietary phosphorus from dairy products but not for phosphorus from other dietary sources. As a whole, our results suggest that dairy foods, but not phosphorus, per se, might have a beneficial effect on BP.
A few previous epidemiological studies have assessed the association of phosphorus intake with BP levels. In the International Study of Macro-and Micro-Nutrients and Blood Pressure, which included 4680 individuals from Japan, China, the United States, and the United Kingdom whose diets were assessed with multiple 24-hour recalls, increments of 2 SDs in phosphorus intake were associated with 2.2-mm Hg and 1.7-mm Hg lower systolic and diastolic BPs in multivariable analysis. 4 Similar results were found among 615 men of Japanese ancestry living in Hawaii, with those in the upper quintile of phosphorus intake, measured with one 24-hour recall, having 3.2-mm Hg lower systolic BP and 2.0-mm Hg lower diastolic BP than those in the lowest quintile, after adjusting for age and body mass index. 26 Finally, a cross-sectional analysis of 4519 US National Health and Nutrition Examination Survey 1999 -2004 participants found that higher phosphorus intake, also assessed with one 24-hour recall, was weakly associated with lower levels of BP (Ϫ0.04 and Ϫ0.03 per each 100 mg of phosphorus per day), 5 although results in the opposite direction were found in US National Health and Nutrition Examination Survey I (1971) (1972) (1973) (1974) (1975) . 27 Overall, existing data, including our results, suggest that higher phosphorus intake is associated with lower BP in cross-sectional analysis. Previous studies, however, did not explore whether this association varied according to dietary source of phosphorus. We have found that only phosphorus from dairy products was associated with lower BP and decreased risk of hypertension in the ARIC Study and MESA. A growing body of evidence suggests that higher consumption of dairy products is associated with lower risk of hypertension. Low-fat dairy products were a substantive part of the combination diet in the Dietary Approaches to Stop Hypertension Trial (the so-called DASH diet). The DASH diet was more effective in reducing BP than a diet rich in fruits and vegetables or a control diet. 2 A number of prospective cohort studies have found lower risk of hypertension in individuals with higher dairy product intake (particularly low-fat dairy), 28 -33 including a recent analysis from the ARIC cohort. 34 Parallel to our results, calcium from dairy products but not from other sources was associated with lower risk of hypertension in another prospective study. 30 Our results highlight, once more, the importance of focusing on foods, in addition to nutrients, in nutritional epidemiology 35 and offer additional evidence of the potential beneficial effect of dairy foods on BP.
No convincing biological mechanism has been provided to explain how dietary phosphorus could reduce BP. Although dietary phosphorus might increase serum phosphorus, 6 -8 and this, in turn, could be associated with lower BP, 36 other studies have shown that dietary phosphorus has a limited impact on serum phosphorus levels. 9 -11 In addition, dietary phosphorus might have deleterious effects on BP. For example, dietary phosphorus loading has been associated with impaired endothelium-dependent vasodilation. 37 Also, higher phosphorus intake could lead to lower levels of circulating 1-25-dihydroxy vitamin D, 6 with lower serum levels of vitamin D associated with higher BP levels. 38 Alternatively, it might be other nutrients in dairy foods, such as calcium, magnesium, potassium, and lactopeptides, or their combination, that are effective in reducing BP levels and the risk of hypertension. 39 The present analysis supports the latter explanation.
Our study has valuable strengths. We have analyzed data from 2 large cohorts, recruited in different areas of the United States and including a multiethnic population. The prospec- and sex; model 2, same as model 1, adjusted additionally for body mass index, waist circumference, eGFR, education, income, physical activity, cigarette smoking, study site, alcohol intake, and energy intake; model 3, same as model 2, adjusted additionally for calcium, vitamin D (only in the ARIC Study), sodium, potassium, magnesium, fruits and vegetables, and whole grains intake.
tive design allowed us to estimate incidence rates of hypertension across categories of phosphorus intake. In addition, BP measurements were performed following cohort-specific standardized protocols, reducing measurement error. We also accounted in the analysis for important potential confounders, particularly multiple lifestyle-related behaviors. Finally, losses to follow-up in both cohorts were limited, reducing the risk for selection bias.
As with other studies in nutritional epidemiology, 1 main limitation of the present analysis is the potential for measurement error in the dietary assessment, particularly relevant for some nutrients, such as sodium. Food questionnaires used in both the ARIC Study and MESA have been validated previously, 20,21 but a certain degree of nondifferential misclassification is unavoidable. We performed a regressioncalibration analysis to partially remediate this problem. Results did not appreciably change after measurement error correction, suggesting that measurement error is unlikely to explain the observed associations.
Another major limitation is the high correlation of phosphorus with other nutrients potentially associated with BP, such as calcium, magnesium, or potassium. High correlations lead to collinearity in multivariable models and, consequently, problems in the estimation of associations. This explains, in part, the large CIs in the association estimates adjusted for other nutrients. High between-nutrient correla- For model 1, Cox proportional hazards model were adjusted for age, race, and sex; model 2, same as model 1, adjusted additionally for body mass index, waist circumference, eGFR, education, income, physical activity, cigarette smoking, study site, alcohol intake, and energy intake; model 3, same as model 2, adjusted additionally for calcium, vitamin D (only in ARIC), sodium, potassium, magnesium, fruits and vegetables, and whole grains intake. Q indicates quintile; ref., reference. Figure 2 . Cross-sectional difference in systolic BP (SBP) levels (and 95% CIs) by quintiles of phosphorus from dairy products (black squares) and phosphorus from nondairy foods (gray circles). Pooled results from the ARIC Study and MESA. Linear regression model adjusted for age, race, sex, body mass index, waist circumference, eGFR, education, income, physical activity, cigarette smoking, study site, alcohol intake, and energy intake.
tion also limits the ability of observational studies to assess the health effects of individual nutrients. 35 Finally, unmeasured or residual confounding is an additional threat. Individuals with low or high phosphorus intake were substantially different in their lifestyles and other potential risk factors for high BP. Although we have controlled for the major risk factors for hypertension, our results might overestimate the true association if healthier individuals had higher phosphorus intake.
Perspectives
We have shown that, in 2 diverse populations, higher phosphorus intake is associated with lower BP levels and a lower risk of hypertension, but these potential benefits seem to be restricted to phosphorus obtained through the intake of dairy products. This finding could be indicative of an effect of phosphorus in conjunction with other dairy constituents or of dairy itself, even without involvement of phosphorus. Additional research is required to determine whether other nutrients in dairy foods, or their combination, are responsible for this association. 
SUPPLEMENTAL METHODS
Assessment of other covariates
In both ARIC and MESA, trained technicians measured height, weight, and waist circumference following a standardized protocol. Diabetes was defined as current use of glucose-lowering medications, fasting glucose 126 mg/dL, nonfasting glucose 200 mg/dL, or, only in ARIC, self-reported history of diabetes. Estimated glomerular filtration rate (eGFR) was calculated using the abbreviated Modification of Diet in Renal Disease Study equation. 1 Current smoking, ethanol intake, income, education, and previous history of cardiovascular disease were ascertained from standardized questionnaires. Physical activity was assessed at baseline using a modification of the Baecke Physical Activity questionnaire in ARIC 2 and an activity questionnaire adapted from the Cross-Cultural Activity Participation Study in MESA. 3 
Statistical analysis
Because concerns exist about the use of Cox regression when the event is measured at discrete points, we repeated the analysis using Poisson (log-link) regression to model the incidence rate ratio of hypertension as a function of predictor covariates with robust variance estimation and an offset for follow-up time.
Statistical models were stratified by race, sex, and eGFR to explore potential interactions. Formal interaction tests were conducted including multiplicative terms in the models, and comparing models with and without interactions with a likelihood ratio test.
Additionally, three supplementary analyses were carried out to evaluate the robustness of our results to different assumptions. First, we repeated the longitudinal analysis defining incident hypertension only based on BP levels, ignoring use of antihypertensive medication, to avoid differences in hypertension diagnosis based on healthcare access or utilization. Second, we performed a longitudinal analysis excluding those with systolic BP ≥130 or diastolic BP ≥80 at baseline to reduce the possibility of including individuals who already had hypertension but were not identified in the baseline exam. Finally, we applied regression calibration to correct for measurement error in dietary intake assessment in both ARIC and MESA using the SAS macro %RELIB. 4 This SAS macro adjusts point and confidence intervals of coefficients obtained from linear and Cox proportional hazards models for measurement error due to random within-person variation, using information from repeated dietary measures in a smaller sample of individuals. Repeatability was determined in 1004 ARIC participants who completed FFQs at baseline and three years later. In this analysis, we estimated the association of an increment of 500 mg of phosphorus intake with systolic BP and the risk of incident hypertension. The analysis corrected measurement error in the intake of the following nutrients: phosphorus, alcohol, calcium, magnesium, potassium, sodium, and total energy intake. The correlation coefficients between the repeated measures were 0.56 (phosphorus), 0.62 (alcohol), 0.55 (calcium), 0.54 (magnesium), 0.55 (potassium), 0.50 (sodium) and 0.58 (total energy intake). No repeatability information was available for MESA.
SUPPLEMENTAL TABLES
Supplemental Supplemental table 5. Difference in systolic blood pressure (SBP) associated with 500 mg/day higher phosphorus intake, before and after correction of measurement error using regression calibration, ARIC and MESA Supplemental table 6. Hazard ratios of hypertension associated with 500 mg/day higher phosphorus intake, before and after correction of measurement error using regression calibration Model 2: Linear regression model adjusted for age, sex, race, total energy intake, alcohol intake, study center, body mass index, waist-to-hip ratio, estimated glomerular filtration rate, education, physical activity and smoking. Model 3: Linear regression model adjusted for same variables as in model 2 plus calcium, magnesium, sodium and potassium intake. Table S6 . Hazard ratios of hypertension associated with 500 mg/day higher phosphorus intake, before and after correction of measurement error using regression-calibration, ARIC, 1987 ARIC, -1998 Model 2: Cox proportional hazards model adjusted for age, sex, race, total energy intake, alcohol intake, study center, body mass index, waist-to-hip ratio, estimated glomerular filtration rate, education, physical activity and smoking. Model 3: Cox proportional hazards model adjusted for same variables as in model 2 plus calcium, magnesium, sodium and potassium intake.
